CONTINUOUS MICRODOSING

Welcome to the Brand page for “CONTINUOUS MICRODOSING”, which is offered here for Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of macular edema, macular disease, retinal disease, glaucoma, and ocular allergy; pharmaceutical preparations for the treatment and prevention of macular edema, macular disease, retinal disease, glaucoma, and ocular allergy;medical apparatus and units for dosage, measuring and monitoring, sustained drug delivery systems for ocular drugs; medical devices and apparatus, surgical implants comprised primarily of artificial material and also incorporating processed animal tissue for use in plastic reconstructive surgery, and repair, reinforcement or buttressing of soft tissue, and parts and fittings therefor;.

Its status is currently believed to be active. Its class is unavailable. “CONTINUOUS MICRODOSING” is believed to be currently owned by “Alimera Sciences, Inc.”